Forefront Wealth Partners’s Zura Bio ZURA Stock Holding History

Forefront Wealth Partners’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-21,518	Closed	-$93.2K	–	204
2025 Q3	$93.2K	Buy	+21,518	New	+$38.7K	0.02%	186

Other funds holding ZURA

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Forefront Wealth Partners's ZURA Position: Q4 2025 in Review

Forefront Wealth Partners sold out of Zura Bio (ZURA) in Q4 2025, closing a stake of 21,518 shares — an estimated $93.2K sold.

Forefront Wealth Partners first reported a position in ZURA in Q3 2025 and held it in 1 quarter. The position peaked at $93.2K in Q3 2025. 75 funds tracked by Wall St. Rank hold ZURA as of Q4 2025.

Forefront Wealth Partners reported no remaining Zura Bio position as of Q4 2025 after selling out during the quarter.
Forefront Wealth Partners sold 21,518 Zura Bio shares in Q4 2025, an estimated $93.2K.
Forefront Wealth Partners first reported a position in Zura Bio in Q3 2025 and held it in 1 quarter.
Forefront Wealth Partners's Zura Bio position peaked at $93.2K in Q3 2025.
75 funds tracked by Wall St. Rank held Zura Bio as of Q4 2025.

Based on Forefront Wealth Partners's 13F filing for Q4 2025, filed 6 Feb 2026.